459 related articles for article (PubMed ID: 28465155)
1. Effect of Liver Disease on Hepatic Transporter Expression and Function.
Thakkar N; Slizgi JR; Brouwer KLR
J Pharm Sci; 2017 Sep; 106(9):2282-2294. PubMed ID: 28465155
[TBL] [Abstract][Full Text] [Related]
2. Liver transporters in hepatic drug disposition: an update.
Li P; Wang GJ; Robertson TA; Roberts MS
Curr Drug Metab; 2009 Jun; 10(5):482-98. PubMed ID: 19689245
[TBL] [Abstract][Full Text] [Related]
3. Role of Hepatic Drug Transporters in Drug Development.
Liu H; Sahi J
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
[TBL] [Abstract][Full Text] [Related]
4. Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review.
Laddha AP; Dzielak L; Lewis C; Xue R; Manautou JE
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167037. PubMed ID: 38295624
[TBL] [Abstract][Full Text] [Related]
5. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
6. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
[TBL] [Abstract][Full Text] [Related]
7. Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.
Canet MJ; Cherrington NJ
Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1209-19. PubMed ID: 24989624
[TBL] [Abstract][Full Text] [Related]
8. Effect of Disease Pathologies on Transporter Expression and Function.
Atilano-Roque A; Roda G; Fogueri U; Kiser JJ; Joy MS
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S205-21. PubMed ID: 27385176
[TBL] [Abstract][Full Text] [Related]
9. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
[TBL] [Abstract][Full Text] [Related]
10. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.
Pan G
Adv Exp Med Biol; 2019; 1141():293-340. PubMed ID: 31571168
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions.
Bohan A; Boyer JL
Semin Liver Dis; 2002; 22(2):123-36. PubMed ID: 12016544
[TBL] [Abstract][Full Text] [Related]
13. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
Varma MV; El-Kattan AF
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps.
Okudaira N
J Pharm Sci; 2017 Sep; 106(9):2251-2256. PubMed ID: 28533120
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
Verbeeck RK
Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
[TBL] [Abstract][Full Text] [Related]
16. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
Ramboer E; Vanhaecke T; Rogiers V; Vinken M
Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
[TBL] [Abstract][Full Text] [Related]
17. Hepatic drug transporters: the journey so far.
Riley RJ; Foley SA; Barton P; Soars MG; Williamson B
Expert Opin Drug Metab Toxicol; 2016; 12(2):201-16. PubMed ID: 26670591
[TBL] [Abstract][Full Text] [Related]
18. A perspective on efflux transport proteins in the liver.
Köck K; Brouwer KL
Clin Pharmacol Ther; 2012 Nov; 92(5):599-612. PubMed ID: 22948894
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
20. [Drug membrane transporters in the liver: regulation of their expression and activity].
Fardel O; Payen L; Sparfel L; Vernhet L; Lecureur V
Ann Pharm Fr; 2002 Nov; 60(6):380-5. PubMed ID: 12514503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
